BioLineRx Ltd.
BLRX
$4.24
-$0.33-7.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 26.37M | 19.56M | 29.17M | 40.06M | 28.17M |
| Total Receivables | 1.92M | 3.86M | 3.96M | 3.84M | 3.34M |
| Inventory | 3.32M | 3.15M | 3.54M | 3.63M | 2.89M |
| Prepaid Expenses | 312.00K | 443.00K | 1.17M | 1.58M | 1.29M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 91.00K | -- | -- | -- |
| Total Current Assets | 31.92M | 27.10M | 37.85M | 49.11M | 35.69M |
|
|
|||||
| Total Current Assets | 31.92M | 27.10M | 37.85M | 49.11M | 35.69M |
| Net Property, Plant & Equipment | 1.16M | 1.35M | 1.65M | 1.80M | 1.72M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 10.43M | 10.45M | 13.25M | 13.69M | 14.19M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 43.51M | 38.91M | 52.74M | 64.60M | 51.60M |
|
|
|||||
| Total Accounts Payable | 4.69M | 5.58M | 4.63M | 6.27M | 8.26M |
| Total Accrued Expenses | -- | 3.13M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.12M | 5.00M | 10.34M | 11.16M | 4.15M |
| Total Finance Division Other Current Liabilities | 4.21M | 1.69M | 9.99M | 13.09M | 11.48M |
| Total Other Current Liabilities | 4.21M | 1.69M | 9.99M | 13.09M | 11.48M |
| Total Current Liabilities | 14.03M | 15.41M | 24.96M | 30.52M | 23.89M |
|
|
|||||
| Total Current Liabilities | 14.03M | 15.41M | 24.96M | 30.52M | 23.89M |
| Long-Term Debt | 7.63M | 8.96M | 17.98M | 18.79M | 5.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 985.00K | 1.08M | 1.29M | 1.31M | 1.23M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 7.49M |
| Total Liabilities | 22.65M | 25.45M | 44.24M | 50.62M | 38.54M |
|
|
|||||
| Common Stock & APIC | 396.20M | 391.79M | 387.44M | 386.84M | 386.84M |
| Retained Earnings | -394.70M | -399.83M | -396.64M | -390.82M | -391.30M |
| Treasury Stock & Other | 19.37M | 21.50M | 17.71M | 17.96M | 17.53M |
| Total Common Equity | 20.86M | 13.46M | 8.51M | 13.98M | 13.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.86M | 13.46M | 8.51M | 13.98M | 13.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.86M | 13.46M | 8.51M | 13.98M | 13.06M |
|
|
|||||